Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paolo Trerotoli"'
Autor:
Paolo Trerotoli, Anna Volpe, Pietro Dentico, Salvatore Antonaci, Felice Marinosci, Gianluigi Giannelli, Michele Quaranta
Publikováno v:
International Journal of Cancer. 117:506-509
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. Because of its increased incidence in the last decade and the estimated further increase in the next 2 decades, HCC is arousing great interest. In Europe and North America,
Autor:
Rahul Agarwal, Paolo Trerotoli, Serena Mancarella, Peter S. Winter, Gianluigi Giannelli, Luigi Lupo, Y. Cao, Francesco Dituri
Publikováno v:
Cell Death & Disease
Transforming growth factor-beta (TGF-β) signaling has gained extensive interest in hepatocellular carcinoma (HCC). The small molecule kinase inhibitor galunisertib, targeting the TGF-β receptor I (TGF-βRI), blocks HCC progression in preclinical mo
Autor:
Gianluigi Giannelli, Anita Mangia, Umberto Filippo Angelotti, Emilia Fransvea, Giovanni Antonaci, Luigi Lupo, Paolo Trerotoli, Salvatore Antonaci, Antonio Mazzocca
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 8, Iss 1, p 29 (2009)
Molecular Cancer, Vol 8, Iss 1, p 29 (2009)
Background This study aimed to investigate squamous cellular carcinoma antigen (SCCA) in serum and in tumoral and paired peritumoral tissues. We studied 27 patients with liver cirrhosis (LC) and 55 with HCC: 20 with a single nodule < 3 cm (s-HCC) and
Autor:
Carlo, Bergamini, Concetta, Sgarra, Paolo, Trerotoli, Luigi, Lupo, Amalia, Azzariti, Salvatore, Antonaci, Gianluigi, Giannelli
Publikováno v:
Hepatology (Baltimore, Md.). 46(6)
Hepatocellular carcinoma (HCC) growth severely affects prognosis. Ki-67, a known marker of cell proliferation, is a negative prognostic factor in HCC. Growth factors such as the epidermal growth factor (EGF) induce HCC cell proliferation but do not e
Autor:
Luigi Lupo, Pietro Dentico, Paolo Trerotoli, Gisèle N'Kontchou, Emilia Fransvea, Felice Marinosci, Gianluigi Giannelli, Salvatore Antonaci, Michel Beaugrand
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 383(1-2)
Background Alpha-fetoprotein (AFP), the only serological marker currently available for the detection of hepatocellular carcinoma (HCC), is unsatisfactory because of its poor sensitivity, as are other recently proposed markers. Therefore new biomarke
Autor:
Stephen Stewart, Joe W. Gray, Paolo Trerotoli, Derek Manas, Gary S. Beale, Gianluigi Giannelli, Dipankar Chattopadhyay, Helen L. Reeves, Christopher P. Day, Mark Hudson
Publikováno v:
BMC Cancer
BMC Cancer, Vol 8, Iss 1, p 200 (2008)
BMC Cancer, Vol 8, Iss 1, p 200 (2008)
Background The incidence and mortality of hepatocellular cancer (HCC) complicating alcoholic and non-alcoholic fatty liver diseases (ALD and NAFLD) is rising in western societies. Despite knowing the at risk populations for HCC development, the lack
Publikováno v:
BMC Medical Research Methodology
BMC Medical Research Methodology, Vol 11, Iss 1, p 38 (2011)
BMC Medical Research Methodology, Vol 11, Iss 1, p 38 (2011)
Background Health service databases of administrative type can be a useful tool for the study of progression of a disease, but the data reported in such sources could be affected by misclassifications of some patients' real disease states at the time